(Updated - August 6, 2018 7:41 AM EDT)(updated to correct prior recommendation)Goldman Sachs upgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from Sell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE